Literature DB >> 19725883

Evolutionary changes to transthyretin: structure-function relationships.

P Prapunpoj1, L Leelawatwattana.   

Abstract

Transthyretin is one of the three major thyroid hormone-binding proteins in plasma and/or cerebrospinal fluid of vertebrates. It transports retinol via binding to retinol-binding protein, and exists mainly as a homotetrameric protein of approximately 55 kDa in plasma. The first 3D structure of transthyretin was an X-ray crystal structure from human transthyretin. Elucidation of the structure-function relationship of transthyretin has been of significant interest since its highly conserved structure was shown to be associated with several aspects of metabolism and with human diseases such as amyloidosis. Transthyretin null mice do not have an overt phenotype, probably because transthyretin is part of a network with other thyroid hormone distributor proteins. Systematic study of the evolutionary changes of transthyretin structure is an effective way to elucidate its function. This review summarizes current knowledge about the evolution of structural and functional characteristics of vertebrate transthyretins. The molecular mechanism of evolutionary change and the resultant effects on the function of transthyretin are discussed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19725883     DOI: 10.1111/j.1742-4658.2009.07243.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  18 in total

1.  Structural study of TTR-52 reveals the mechanism by which a bridging molecule mediates apoptotic cell engulfment.

Authors:  Yanyong Kang; Dongfeng Zhao; Huanhuan Liang; Bin Liu; Yan Zhang; Qinwen Liu; Xiaochen Wang; Yingfang Liu
Journal:  Genes Dev       Date:  2012-06-15       Impact factor: 11.361

2.  Heparan sulfate/heparin promotes transthyretin fibrillization through selective binding to a basic motif in the protein.

Authors:  Fredrik Noborn; Paul O'Callaghan; Erik Hermansson; Xiao Zhang; John B Ancsin; Ana M Damas; Ingrid Dacklin; Jenny Presto; Jan Johansson; Maria J Saraiva; Erik Lundgren; Robert Kisilevsky; Per Westermark; Jin-Ping Li
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-21       Impact factor: 11.205

3.  Clinical Cancer Nanomedicine.

Authors:  Joy Wolfram; Mauro Ferrari
Journal:  Nano Today       Date:  2019-03-06       Impact factor: 20.722

Review 4.  The supramolecular chemistry of β-sheets.

Authors:  Pin-Nan Cheng; Johnny D Pham; James S Nowick
Journal:  J Am Chem Soc       Date:  2013-04-02       Impact factor: 15.419

5.  Gene structure and evolution of transthyretin in the order Chiroptera.

Authors:  Jiraporn Khwanmunee; Ladda Leelawatwattana; Porntip Prapunpoj
Journal:  Genetica       Date:  2015-12-17       Impact factor: 1.082

6.  Reenacting the Birth of a Function: Functional Divergence of HIUases and Transthyretins as Inferred by Evolutionary and Biophysical Studies.

Authors:  Lucas Carrijo de Oliveira; Mariana Amalia Figueiredo Costa; Natan Gonçalves Pedersolli; Fernanda Aparecida Heleno Batista; Ana Carolina Migliorini Figueira; Rafaela Salgado Ferreira; Ronaldo Alves Pinto Nagem; Laila Alves Nahum; Lucas Bleicher
Journal:  J Mol Evol       Date:  2021-05-06       Impact factor: 2.395

7.  Post-translational modifications of transthyretin affect the triiodonine-binding potential.

Authors:  Andrea Henze; Thomas Homann; Mustafa Serteser; Ozge Can; Ozlem Sezgin; Abdurrahman Coskun; Ibrahim Unsal; Florian J Schweigert; Aysel Ozpinar
Journal:  J Cell Mol Med       Date:  2014-10-14       Impact factor: 5.310

8.  Tracing thyroid hormone-disrupting compounds: database compilation and structure-activity evaluation for an effect-directed analysis of sediment.

Authors:  Jana M Weiss; Patrik L Andersson; Jin Zhang; Eszter Simon; Pim E G Leonards; Timo Hamers; Marja H Lamoree
Journal:  Anal Bioanal Chem       Date:  2015-05-19       Impact factor: 4.142

9.  Binding site asymmetry in human transthyretin: insights from a joint neutron and X-ray crystallographic analysis using perdeuterated protein.

Authors:  Melina Haupt; Matthew P Blakeley; Stuart J Fisher; Sax A Mason; Jon B Cooper; Edward P Mitchell; V Trevor Forsyth
Journal:  IUCrJ       Date:  2014-10-21       Impact factor: 4.769

10.  Feasibility of investigating differential proteomic expression in depression: implications for biomarker development in mood disorders.

Authors:  M A Frye; M Nassan; G D Jenkins; S Kung; M Veldic; B A Palmer; S E Feeder; S J Tye; D S Choi; J M Biernacka
Journal:  Transl Psychiatry       Date:  2015-12-08       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.